Clinical Trial

A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 23, 2026 (before its estimated August 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
To assess pharmacokinetics, safety, and tolerability of multiple oral doses of verducatib in healthy Chinese male and female trial participants in order to facilitate the clinical development of verducatib in China.
Protocol Amendment History 4 changes
notable Enrollment increased: 9 -> 12 participants 2026-07-24
minor Completion moved earlier: 2026-10-14 -> 2026-08-21 2026-07-24
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-07-01
notable Enrollment reduced: 12 -> 9 participants 2026-07-01
Trial Details
NCT Number NCT07531628
Lead Sponsor Boehringer Ingelheim
Conditions Healthy
Enrollment 12 participants
Start Date 2026-06-10
Primary Completion 2026-08-10 (estimated)
Study Completion 2026-08-21 (estimated)
Updated on ClinicalTrials.gov 2026-07-23